Annual Report — Form 10-K — SEA’34
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 2.14M
2: EX-4.3 Instrument Defining the Rights of Security Holders HTML 45K
3: EX-23.1 Consent of Expert or Counsel HTML 26K
7: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 41K
Awarded Compensation
4: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
6: EX-32 Certification -- §906 - SOA'02 HTML 29K
13: R1 Cover HTML 92K
14: R2 Audit Information HTML 32K
15: R3 Consolidated Balance Sheets HTML 123K
16: R4 Consolidated Balance Sheets (Parenthetical) HTML 62K
17: R5 Consolidated Statements of Operations and HTML 85K
Comprehensive Loss
18: R6 Consolidated Statements of Redeemable Convertible HTML 131K
Preferred Stock and Stockholders? Equity (Deficit)
19: R7 Consolidated Statements of Redeemable Convertible HTML 33K
Preferred Stock and Stockholders? Equity (Deficit)
(Parenthetical)
20: R8 Consolidated Statements of Cash Flows HTML 131K
21: R9 Consolidated Statements of Cash Flows HTML 29K
(Parenthetical)
22: R10 Description of Business, Organization and HTML 37K
Liquidity
23: R11 Summary of Significant Accounting Policies HTML 69K
24: R12 ValenzaBio Acquisition HTML 48K
25: R13 Fair Value Measurements HTML 84K
26: R14 Available-For-Sale Marketable Securities HTML 59K
27: R15 Consolidated Balance Sheet Components HTML 66K
28: R16 Significant Agreements HTML 44K
29: R17 Commitments and Contingent Liabilities HTML 50K
30: R18 Redeemable Convertible Preferred Stock HTML 50K
31: R19 Derivative Tranche Liability HTML 30K
32: R20 Common Stock HTML 44K
33: R21 Equity Incentive Plan HTML 109K
34: R22 Related Party Transactions HTML 32K
35: R23 Net Loss Per Share Attributable to Common HTML 51K
Stockholders
36: R24 Income Taxes HTML 80K
37: R25 Subsequent Events HTML 29K
38: R26 Summary of Significant Accounting Policies HTML 119K
(Policies)
39: R27 ValenzaBio Acquisition (Tables) HTML 38K
40: R28 Fair Value Measurements (Tables) HTML 86K
41: R29 Available-For-Sale Marketable Securities (Tables) HTML 58K
42: R30 Consolidated Balance Sheet Components (Tables) HTML 70K
43: R31 Commitments and Contingent Liabilities (Tables) HTML 41K
44: R32 Redeemable Convertible Preferred Stock (Tables) HTML 40K
45: R33 Common Stock (Tables) HTML 37K
46: R34 Equity Incentive Plan (Tables) HTML 96K
47: R35 Net Loss Per Share Attributable to Common HTML 52K
Stockholders (Tables)
48: R36 Income Taxes (Tables) HTML 88K
49: R37 Description of Business, Organization and HTML 88K
Liquidity (Details)
50: R38 Summary of Significant Accounting Policies HTML 48K
(Details)
51: R39 ValenzaBio Acquisition - Narrative (Details) HTML 104K
52: R40 ValenzaBio Acquisition - Schedule of Total HTML 46K
Purchase Consideration (Details)
53: R41 ValenzaBio Acquisition - Schedule of Allocation of HTML 40K
Purchase Consideration (Details)
54: R42 Fair Value Measurements - Schedule of Financial HTML 78K
Instruments Measured on Recurring Basis (Details)
55: R43 Fair Value Measurements - Schedule of Cash and HTML 34K
Cash Equivalents and Marketable Securities
(Details)
56: R44 Fair Value Measurements - Summary of Changes in HTML 37K
Level 3 Liabilities (Details)
57: R45 Fair Value Measurements - Narrative (Details) HTML 47K
58: R46 Fair Value Measurements - Summary of Significant HTML 40K
Assumptions Used to Estimate Fair Value (Details)
59: R47 Available-For-Sale Marketable Securities - HTML 61K
Schedule of Available-for-Sale Marketable
Securities (Details)
60: R48 Available-For-Sale Marketable Securities - HTML 39K
Narrative (Details)
61: R49 Consolidated Balance Sheet Components - Schedule HTML 41K
of Prepaid and Other Current Assets (Details)
62: R50 Consolidated Balance Sheet Components - Schedule HTML 37K
of Prepaid and Other Noncurrent Assets (Details)
63: R51 Consolidated Balance Sheet Components - Property, HTML 44K
Plant and Equipment (Details)
64: R52 Consolidated Balance Sheet Components - Accrued HTML 32K
Research and Development Expense (Details)
65: R53 Consolidated Balance Sheet Components - Schedule HTML 37K
of Accrued Compensation and Other Current
Liabilities (Details)
66: R54 Significant Agreements (Details) HTML 73K
67: R55 Commitments and Contingent Liabilities - Narrative HTML 79K
(Details)
68: R56 Commitments and Contingent Liabilities - Schedule HTML 37K
of Non-cancellable Purchase Obligations (Details)
69: R57 Commitments and Contingent Liabilities - Summary HTML 51K
of Maturity Analysis of Operating Lease Liability
(Details)
70: R58 Redeemable Convertible Preferred Stock - Narrative HTML 62K
(Details)
71: R59 Redeemable Convertible Preferred Stock - Schedule HTML 61K
of Convertible Preferred Stock (Details)
72: R60 Derivative Tranche Liability (Details) HTML 49K
73: R61 Common Stock - Narrative (Details) HTML 47K
74: R62 Common Stock - Schedule of Common Stock Reserved HTML 48K
for Future Issuance (Details)
75: R63 Equity Incentive Plan - Narrative (Details) HTML 242K
76: R64 Equity Incentive Plan - Summary of Stock Option HTML 82K
Activity (Details)
77: R65 Equity Incentive Plan - Summary of Restricted HTML 52K
Stock Unit Activity (Details)
78: R66 Equity Incentive Plan - Summary of Performance HTML 51K
Share Activity (Details)
79: R67 Equity Incentive Plan - Schedule of Valuation HTML 54K
Assumptions (Details)
80: R68 Equity Incentive Plan - Schedule of Compensation HTML 53K
Expense (Details)
81: R69 Related Party Transactions (Details) HTML 31K
82: R70 Net Loss Per Share Attributable to Common HTML 64K
Stockholders - Schedule of Basic and Diluted Net
Loss Per Share (Details)
83: R71 Net Loss Per Share Attributable to Common HTML 45K
Stockholders - Schedule of Outstanding Shares Of
Potentially Dilutive Securities (Details)
84: R72 Income Taxes - Narrative (Details) HTML 37K
85: R73 Income Taxes - Schedule of Effective Income Tax HTML 44K
Rate Reconciliation (Details)
86: R74 Income Taxes - Schedule of Deferred Tax Assets HTML 52K
(Details)
87: R75 Income Taxes - Summary of Operating Loss HTML 34K
Carryforwards and Tax Credit Carryforwards
(Details)
88: R76 Income Taxes - Summary of Uncertain Tax Positions HTML 34K
(Details)
89: R77 Subsequent Events (Details) HTML 41K
91: XML IDEA XML File -- Filing Summary XML 171K
94: XML XBRL Instance -- slrn-20231231_htm XML 1.77M
90: EXCEL IDEA Workbook of Financial Report Info XLSX 197K
9: EX-101.CAL XBRL Calculations -- slrn-20231231_cal XML 217K
10: EX-101.DEF XBRL Definitions -- slrn-20231231_def XML 809K
11: EX-101.LAB XBRL Labels -- slrn-20231231_lab XML 1.80M
12: EX-101.PRE XBRL Presentations -- slrn-20231231_pre XML 1.28M
8: EX-101.SCH XBRL Schema -- slrn-20231231 XSD 209K
92: JSON XBRL Instance as JSON Data -- MetaLinks 527± 822K
93: ZIP XBRL Zipped Folder -- 0001962918-24-000032-xbrl Zip 665K
‘EX-97.1’ — Clawback Policy re: Recovery of Erroneously Awarded Compensation
This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]